Advertisement

Oxidation of Human Low Density Lipoprotein Initiated by Copper(II)Chloride

  • Oswald Quehenberger
  • Günther Jürgens
  • Silvia Zadravec
  • Hermann Esterbauer
Part of the Basic Life Sciences book series (BLSC, volume 49)

Abstract

Human low density lipoprotein (LDL) is a complex of a glycoprotein (apo B), free and esterified cholesterol, phospholipids, triglycerides and lipid soluble vitamins. It has been shown that oxidative modification of LDL mediated by free radical reactions renders LDL recognizable by the scavenger receptors of macrophages, cytotoxic towards fibroblasts and chemotactic towards monocytes.1,4 These and other properties of oxidized LDL might play an important role in atherogenesis. We have shown that oxidized LDL contains a great variety of aldehydes, such as 4-hydroxynonenal (HNE), derived from the oxidative breakdown of the polyunsaturated fatty acids. Moreover, the apo B of oxidized LDL exhibits a strong fluorescence at 360 nm excitation and 430 nm emission, which we attributed to covalent binding of HNE.5,6 Traces of metal ions, such as copper or iron, are most probably involved in the initiation of oxidation reactions in LDL. The aim of this investigation was to study the capacity of bivalent copper ions to initiate lipid peroxidation in LDL.

Keywords

Copper Concentration High Copper Concentration Initiate Lipid Peroxidation Lipid Soluble Vitamin Lower Copper Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. Henriksen, E.M. Mahoney, and D. Steinberg, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells : Recognition by receptors for acetylated low density lipoproteins, Proc. Natl. Acad. Sci. U.S.A. 78:6499 (1981).PubMedCrossRefGoogle Scholar
  2. 2.
    U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witzturn, and D. Steinberg, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl. Acad. Sci. U.S.A. 81:3883 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    M.F. Haberland, A.M. Fogelman, and P.A. Edwards, Specificity of receptor-mediated recognition of malondialdehyde modified low density lipoproteins, Proc. Natl. Acad. Sci. U.S.A. 79:1712 (1982).PubMedCrossRefGoogle Scholar
  4. 4.
    D.W. Morel, J.R. Hessler, and G.M. Chisolm, Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid, J. Lipid Res. 24:1070 (1983).PubMedGoogle Scholar
  5. 5.
    O. Quehenberger, E. Koller, G. Jurgens, and H. Esterbauer, Investigation of lipid peroxidation in human low density lipoprotein, Free Rad. Res. Commun. 3:233 (1987).CrossRefGoogle Scholar
  6. 6.
    H. Esterbauer, G. Jurgens, O. Quehenberger, and E. Koller, Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J. Lipid Res. 28:495 (1987).PubMedGoogle Scholar
  7. 7.
    J. Lang, C. Celotto, and H. Esterbauer, Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high performance liquid chromatography, Anal. Biochem. 150:369 (1985).PubMedCrossRefGoogle Scholar
  8. 8.
    K. Yagi, Assay for serum lipid peroxide level and its clinical significance, in: “Lipid Peroxides in Biology and Medicine,” K. Yagi, ed., Academic Press, New York (1982).Google Scholar
  9. 9.
    Esterbauer, E. Koller, R. Slee, and J.F. Koster, Possible involvement of the lipid peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids, Bichem. J. 239:405 (1986).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Oswald Quehenberger
    • 1
  • Günther Jürgens
    • 1
  • Silvia Zadravec
    • 1
  • Hermann Esterbauer
    • 1
  1. 1.Institute of Biochemistry and Institute of Medical BiochemistryUniversity of GrazGrazAustria

Personalised recommendations